Getting lost along the way is part of the adventure. That’s what skater Cassandra Ablack — who will appear in the Disney on Ice production “Jump In!,” running Jan. 14 through 18 at Cleveland’s Rocket ...
Rocket Lab's latest deal, worth a potential $805 million, is larger than the company's trailing 12-month revenue. Similarly, it nearly equals the company's existing backlog of $1.1 billion. Most ...
Rocket Lab (NASDAQ: RKLB) surged over 10% on massive volume, officially catalyzed by news that its 'Hungry Hippo’ cargo, fairing for the next-gen Neutron rocket, passed final testing, alongside ...
The company that pioneered small launch has had a big year. Rocket Lab broke its annual launch record with the Electron booster—17 successful missions this year, and counting—and is close to bringing ...
After its most recent successful New Glenn mission, Blue Origin is announcing propulsion upgrades to its star rocket, and plans for a larger "super-heavy class rocket" that puts the company in even ...
The lower half of the New Glenn rocket set down on a platform in the Atlantic Ocean after lifting a small NASA Mars mission to space. By Kenneth Chang Kenneth Chang reported on the first flight of the ...
ROME, Nov 10 (Reuters) - Raytheon and Lockheed Martin (LMT.N), opens new tab will be the major customers of Avio's (AVI.MI), opens new tab planned solid rocket motor plant in the United States, the ...
MOUNTAIN VIEW, Calif. — Fresh questions are emerging over Rocket Lab’s proposed acquisition of German laser communications firm Mynaric as Europe doubles down on its push for domestic space and ...
A Canadian who has worked in the gaming industry for over two decades, Beck grew up on games such as Final Fantasy and Super Mario Bros. He specalizes in roleplaying games, but covers titles in almost ...
A NASA ROCKET MAY BE VISIBLE OVER THE SUSQUEHANNA VALLEY TONIGHT. VERY EXCITING. AND NASA SAYS IT’S AIMING TO LAUNCH ITS TOME X PLUS ROCKET BETWEEN 10:00 TONIGHT AND THREE IN THE MORNING. OKAY, SO IF ...
Rocket Pharmaceuticals' shares rallied ahead of the opening bell after the Food and Drug Administration lifted its clinical hold on the biotechnology company's Phase 2 trial of its RP-A501 treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results